These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30739377)

  • 1. Chronic hepatitis B: The interplay between intrahepatic lymphocyte population and viral antigens in relation to liver damage.
    Giadans CG; Ríos DA; Ameigeiras B; Pietrantonio AM; Lucatelli NL; Haddad L; Mullen E; Heinrich F; De Matteo E; Flichman D; Valva P; Preciado MV
    J Viral Hepat; 2019 Jun; 26(6):727-737. PubMed ID: 30739377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic immune infiltrate in chronic hepatitis B and chronic hepatitis C: Similar but not the same.
    Giadans CG; Ríos DA; Ameigeiras B; Haddad L; De Matteo EN; Valva P; Preciado MV
    J Viral Hepat; 2022 Feb; 29(2):124-134. PubMed ID: 34820942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states.
    Zhang M; Zhou J; Zhao T; Huang G; Tan Y; Tan S; Fu X; Niu W; Meng G; Chen X; Shang X; Liu D; Ni B; Wang L; Wu Y
    J Infect Dis; 2012 Apr; 205(7):1111-20. PubMed ID: 22357657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients.
    Yim SY; Kim TH; Jun SS; Kim ES; Keum B; Seo YS; Yim HJ; Jeen YT; Chun HJ; Lee HS; Um SH; Kim CD; Won NH; Ryu HS
    Gut Liver; 2017 May; 11(3):417-425. PubMed ID: 28208002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection.
    Tang TJ; Kwekkeboom J; Laman JD; Niesters HG; Zondervan PE; de Man RA; Schalm SW; Janssen HL
    J Viral Hepat; 2003 May; 10(3):159-67. PubMed ID: 12753333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease.
    Cairoli V; De Matteo E; Rios D; Lezama C; Galoppo M; Casciato P; Mullen E; Giadans C; Bertot G; Preciado MV; Valva P
    Sci Rep; 2021 Mar; 11(1):5129. PubMed ID: 33664397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core antigen expression is associated with hepatic necroinflammation in e antigen-negative chronic hepatitis B patients with low DNA loads.
    Huang YH; Hung HH; Chan CC; Lai CR; Chu CJ; Huo TI; Lee PC; Su CW; Lan KH; Huang HC; Lee IC; Lin HC; Lee SD
    Clin Vaccine Immunol; 2010 Jun; 17(6):1048-53. PubMed ID: 20427626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
    Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
    J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
    Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
    Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients.
    Tang TJ; de Man RA; Kusters JG; Kwekkeboom J; Hop WC; van der Molen RG; Schalm SW; Janssen HL
    J Med Virol; 2004 Feb; 72(2):215-22. PubMed ID: 14695662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection.
    Jung MC; Diepolder HM; Spengler U; Wierenga EA; Zachoval R; Hoffmann RM; Eichenlaub D; Frösner G; Will H; Pape GR
    J Virol; 1995 Jun; 69(6):3358-68. PubMed ID: 7538172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
    Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
    World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg decline.
    Arends P; Rijckborst V; Zondervan PE; Buster E; Cakaloglu Y; Ferenci P; Tabak F; Akarca US; Simon K; Sonneveld MJ; Hansen BE; Janssen HL
    J Viral Hepat; 2014 Dec; 21(12):897-904. PubMed ID: 24444353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B.
    Lai Q; Ma S; Ge J; Huang Z; Huang X; Jiang X; Li Y; Zhang M; Zhang X; Sun J; Abbott WG; Hou J
    PLoS One; 2014; 9(2):e88475. PubMed ID: 24551107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection.
    Feng IC; Koay LB; Sheu MJ; Kuo HT; Sun CS; Lee C; Chuang WL; Liao SK; Wang SL; Tang LY; Cheng CJ; Tsai SL
    J Biomed Sci; 2007 Jan; 14(1):43-57. PubMed ID: 17109186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of circulating CD56
    Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
    Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B.
    Sprengers D; van der Molen RG; Kusters JG; Hansen B; Niesters HG; Schalm SW; Janssen HL
    J Med Virol; 2006 May; 78(5):561-8. PubMed ID: 16555293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
    Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
    Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The characteristic of T cells response to HBV-specific antigen proteins in patients with HBV infection].
    Feng X; Yan HP; Liao HY; Liu YM; Zhang GY; Lin F; Zhao Y; Huang YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):253-5. PubMed ID: 23189836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.